EPIZYME
Epizyme is a biopharmaceutical company located in Cambridge, MA, that is focused on researching treatments for blood cancer and tumors. Founded in late 2007, the company has brought together premier academic and industry leaders to rapidly translate the exciting discoveries emerging from epigenetic research into specific programs that will produce important, novel, molecularly targeted drugs of the future.
EPIZYME
Industry:
Biopharma Biotechnology Health Care
Founded:
2007-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.epizyme.com
Total Employee:
101+
Status:
Active
Contact:
1(617)349-0707
Email Addresses:
[email protected]
Total Funding:
834.08 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics
Current Advisors List
![]()
![]()
![]()
![]()
![]()
Current Employees Featured
![]()
![]()
![]()
Founder
![]()
![]()
Stock Details
Investors List
![]()
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Equity - Epizyme
Royalty Pharma
Royalty Pharma investment in Post-IPO Equity - Epizyme
![]()
Celgene
Celgene investment in Post-IPO Equity - Epizyme
![]()
GlaxoSmithKline
GlaxoSmithKline investment in Venture Round - Epizyme
![]()
Leukemia & Lymphoma Society
Leukemia & Lymphoma Society investment in Venture Round - Epizyme
Multiple Myeloma Research Foundation
Multiple Myeloma Research Foundation investment in Grant - Epizyme
![]()
New Enterprise Associates
New Enterprise Associates investment in Series B - Epizyme
Kleiner Perkins
Kleiner Perkins investment in Series B - Epizyme
![]()
Astellas Venture Management
Astellas Venture Management investment in Series B - Epizyme
![]()
Amgen Ventures
Amgen Ventures investment in Series B - Epizyme
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-15 | Epizyme Announces Executive Appointment and Provides Tazemetostat Clinical Update |
| 2021-08-09 | Epizyme Announces CEO Succession |
| 2020-03-23 | Epizyme Names Infinityโs Jeffery Kutok as Chief Scientific Officer |
Official Site Inspections
http://www.epizyme.com Semrush global rank: 7.1 M Semrush visits lastest month: 594
- Host name: a4ec4c6ea1c92e2e6.awsglobalaccelerator.com
- IP address: 3.33.152.147
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
